At the SANTHE mtg (santheafrica.org) in Kigali. So great to see partners deepening their know-how as champions for #HIV cure research. Miliswa Magongo, former Wits RHI engagement specialist, is getting her PhD on HIV cure! More cure resources and opportunities for advocates here: buff.ly/8V3OoS3

Today @TheNewYorker released our short documentary “Rovina’s Choice” online. It traces the ongoing effects of the sudden shutdown of US foreign aid through the story of one mother in Kenya as she seeks to save her daughter from sickness and starvation. 🎥 1/ www.newyorker.com/culture/the-...

Fanastic piece by @sarajerving.bsky.social of @devex.com with @jirairratevosian.bsky.social @gostin.bsky.social & @globalhealthorg.bsky.social on the future of global health. As our ED said, “This administration moves w/reckless abandon — & Congress moves not at all.” www.devex.com/news/america...

MUST READ | The number of HIV viral load tests recorded by the National Health Laboratory Service is significantly less than expected since Feb 2025. Spotlight and @groundup.org.za are aware of no compelling reason to explain this except the US aid withdrawal. www.spotlightnsp.co.za/2025/11/04/w...

📢 New from AVAC: This week’s roundup covers tools for injectable #lenacapavir rollout, updates on AVAC’s #foreignaid court case, defending health rights for key pops, #DualPreventionPill progress, #STI & HIV cure advocacy tools, and more. Read: buff.ly/P3OyH0L

Missed the Beyond Borders webinar hosted by ISSTDR, IUSTI, #STIHIV2025 Congress, and AVAC? Catch up now with the full recording + presentation slides—spotlighting powerful #STI research from presenters blocked by financial and political barriers. 📍 Resources: buff.ly/9owSqIh #STIWatch

Are you attending #icfp2025 in Bogata this week? Don't miss the Wednesday, Nov 5 panel discussion, The Dual Prevention Pill Introduction Plan: Both a Question and an Answer to Integration. Learn more at buff.ly/69Lbu06

Two must-read pieces on AVAC + @globalhealthorg.bsky.social cases on #foreignaid: 1️⃣ Foreign aid on uncertain legal footing: www.nytimes.com/2025/11/03/u... 2️⃣ SCOTUS expands exec power over tariffs: www.washingtonpost.com/politics/202... @publiccitizen.bsky.social #globalhealth

Thanks to health leaders Emily Bass, Mitchell Warren, Asia Russell, Amanda Banda, and Isata Dumbuya. And to our event co-hosts UNAIDS, Health GAP, People's Medicines Alliance, UAEM, Treatment Action Group, RESULTS, and Partners In Health.

This week in #GlobalHealthWatch: 1) 🇿🇦 SA approves injectable #LEN for #PrEP, the first in Africa 2) US releases a draft #globalhealth MoU w/major gaps in #HIVprevention & community voice 3) Leaked EU doc suggests future cuts to Gavi & the Global Fund avac.org/blog/global-...

New in Sexually Transmitted Infections: Self-testing ≠ self-collection. This editorial from AVAC’s Alison Footman and colleagues makes the case for precise & consistent language because clarity impacts policy, expectations, and access. Read: sti.bmj.com/content/earl... #STIs #SRHR #SelfTesting

Just out in @thelancet.com: an important new series on innovations in #SRH. From new contraceptive R&D to cost effectiveness of interventions, the series highlights the need for improving SRH. Read: www.thelancet.com/journals/lan... And join the launch event: avac.org/event/innova... #STI #HIV

Building a sustainable market for #LEN for #PrEP is a top priority for the HIV response right now. Get details & resources on this and other critical issues at buff.ly/NP7L0Gj

Today’s webinar, Do Not Check That Box – Impacts From the Assault on Transgender Communities and DEI + Strategies to Sustain and Rebuild, hosted by the Choice Agenda, assessed the devastating impact from US presidential executive orders. asaradix.bsky.social jncherabiemd.bsky.social

Webinar happening now! Do Not Check That Box – Impacts From the Assault on Transgender Communities and DEI + Strategies to Sustain and Rebuild. Hosted by The Choice Agenda. Register here avac-org.zoom.us/meeting/regi...

#LEN for #PrEP is moving faster toward rollout than any previous #PrEP product, but so much still needs to happen: such as aligning global funders and nailing down price. Speeding access to #LEN is a critical priority for the field, learn more at avac.org/lenacapvir

Happening Soon! ⬇️ Register: www.stiwatch.org/event/beyond...

📣 Don't miss two important conversations Wednesday: 🔹 Beyond Borders: A webinar spotlighting STI & HIV research from voices often excluded due to financial or political barriers. 🔹 Do Not Check That Box: A convo on the impacts of the Assault on Transgender Communities 👉 Register: buff.ly/RncZaKC

South Africa’s regulators just approved #LEN for #PrEP, the fastest Africa approval of #PrEP ever. More approvals are pending in KE, MW, ZM & ZW. It's great progress, but critical steps still remain to translate this option into a real choice. Track long-acting #PrEP rollout at buff.ly/SWsEa9M

AVAC: Transforming HIV Prevention in 2025: Advocates’ Critical Questions bit.ly/48S3kaK @avac.org lenacapavir PrEP

Global health is shifting fast and advocates are asking big questions: 1️⃣ How do we speed access to #lenacapavir for #PrEP? 2️⃣ How is the field adapting to shrinking #globalhealth funding? 3️⃣ What’s next for the #HIV prevention R&D pipeline? Explore the answers + key resources 👉 buff.ly/NP7L0Gj

"SAHPRA's approval of #lenacapavir is a historic moment for #HIVprevention in South Africa...The real work begins now through ensuring that every person who could benefit from lenacapavir knows about it, can access it, and chooses to use it." - APHA's Yvette Raphael Read: tinyurl.com/h84f8f27

#SouthAfrica becomes first African country to register the lenacapavir, the twice-a-year anti-HIV jab — at record speed bhekisisa.org/health-news-... @bhekisisa.org @linda-gailb.bsky.social

❗❗New issue of #globalhealthwatch is out covering development finance, the real-time impact of #foreignaid cuts + new #PrEP resources to track PrEP access, pricing and the pipeline. Read here: avac.org/blog/global-...

Effective integration of HIV services for Key Populations (KP) in healthcare depends on 2 non-negotiable elements: person-sensitive care and leadership from KP communities. AVAC's Richard Muko presented these public health priorities at Africa’s #CPHIA2025 conference. Learn more at buff.ly/TW5Lat4

foreignpolicy.com's podcast today explores "The Promise of PrEP for HIV" (esp lenacapavir), featuring AVAC partners Kenneth Mwehonge of HEPS Uganda+Flavia Latovu Kiweewa of MU-JHU @johnshopkinssph.bsky.social+Wafaa El-Sadr @icapcolumbia.bsky.social. Listen here: foreignpolicy.com/podcasts/the...

Our new #PxWire issue is out! It tracks funders & countries rolling out new #PrEP products; compares their prices; and shows sites launching the 1xmonth pill. Read it all here: avac.org/pxwire/ @eltonjohnaidsfoundation.org @ciffchild.bsky.social @gatesfoundation.bsky.social @unitaid.bsky.social

So excited for the screening of Ending HIV: The Journey to a Vaccine, an award winner at the #RawScience2025 film festival in NYC on Sat. The documentary tells the story of the HIV Vaccine Trials Network’s trailblazing research on HIV vaccines. Learn more at buff.ly/12nc1SJ

Our #STI civil society partners in Kenya, Lesotho, Malawi, South Africa, Zambia, Uganda & Zimbabwe are helping to reshape the STI R&D and diagnostics agenda in East and Southern Africa. 🔗 Read how ➡️ www.stiwatch.org/moving-the-s... #STIAdvocacy #STIWatch #HIVprevention #GlobalHealth

Don't miss this webinar! Join @avac_org, @isstdr, @iusti_org & the @sti-hiv-2025 team for a powerful webinar spotlighting researchers excluded from the #STIHIV2025 due to financial/political barriers.Ppresenters will share findings & chart what’s next for the field. #STIs #HIVprevention

Check out the latest from @pozmagazine.bsky.social on injectable #PrEP, www.poz.com/article/cabo.... Learn more about both CAB and LEN options at www.prepwatch.org, your go-to resource for info to help effectively deliver every proven method of #HIV PrEP to everyone who needs it.

1 in 10 clinics across 6 provinces could soon hand out the 6-monthly #HIV prevention shot #LEN. Modelling shows it could end #AIDS in 14–18 years — if enough people use it. Who should get it first? bhekisisa.org/health-news-...

When US aid ended earlier this year, a Somali maternity hospital had to fire staff + close. But not everyone got the news. When one woman arrived in late stage labor + gave birth outside the locked gate, the staff came back to work. They're still working for free. www.nytimes.com/2025/10/17/h...

It’s finally here! The Scorecard for Trans Inclusion in HIV Research is now in print in the October issue of AJPH. Pages 1621-1630 babyyyyy! Representation looks good on you Brian Minalga! READ: ajph.aphapublications.org/doi/10.2105/... @avac.org @amjpublichealth.bsky.social

About two weeks away from this webinar focused on highlighting presenters who could not attend the STI & HIV 2025 World Congress due to financial and political barriers. Register at www.stiwatch.org/event/beyond...

#GlobalHealth leaders call for consolidation; chaos across US health agencies with layoffs and reinstatements; a donor retracts from US non-profits, all this & more in today's issue of #GlobalHealthWatch buff.ly/nDzW9oY

An important interview with the brilliant Yvette Raphael of @aphaza.bsky.social on #lenacapavir for #HIVprevention and #PrEP in this moment. "...it will help the country [South Africa] to avert many HIV infections if we roll it out correctly." ▶️ Watch the full interview: youtu.be/HNXmMgE6WA8?...

At the #STATSummit, we asked Rochelle Walensky:"What are you most worried about for the next decade in science and medicine?" Her reply 👇

Must-read from @vox.com Amid the #foreignaid freeze and rising threats to #HIV programs, the story of injectable #lenacapavir for #PreP shows what’s at stake, and what’s still possible. #PEPFAR #HIVprevention Read: buff.ly/ao9nnko

NYT: They Fought Outbreaks Worldwide. Now They’re Fighting for New Lives. by @apoorvanyt.bsky.social nyti.ms/4hazsrZ

The first reports of what would eventually be called AIDS and its causative agent identified as HIV were published in the MMWR in 1981 alerting health care and public health systems across the country. A tremendous loss for public health.

It was yet another rough night for CDC employees: Dozens — possibly hundreds, they are still self-surveying — were let go late at night, including those who worked on the prestigious MMWR reports www.nytimes.com/2025/10/11/u...

WHO: First lenacapavirs prequalified bit.ly/4obiJHc lenacapavir PrEP

In the midst of profound disruptions to US leadership in #globalhealth, the world has seen sustained momentum behind the rollout of injectable #lenacapavir for #PrEP. This and more in our latest roundup of resources, avac.org/blog/oct2025...

Funding cuts threaten the delivery of a new HIV prevention injection that is set to roll out in 2027. #SciComm www.scidev.net/global/news/...

As the US gov’t shutdown drags on, #globalhealth hangs in the balance. But amid the chaos, a bright spot: WHO has prequalified injectable #lenacapavir for #PrEP, fast-tracking its access. Read more in this week’s #GlobalHealthWatch. 🔗 avac.org/blog/global-...

Today my @nytimes.com colleagues and I are launching a new series called Lost Science. We interview US scientists who can no longer discover something new about our world, thanks to this year‘s cuts. Here is my first interview with a scientist who studied bees and fires. Gift link: nyti.ms/3IWXbiE

Since 1997, the Research in Action Awards have raised over $4.8 million to drive our work to end HIV, hepatitis C, and tuberculosis. A huge thank you to our generous sponsors — your support makes this celebration possible and helps honor the change makers shaping the future of health equity

Thanks @politico.com's Cheyanne Daniels, @egpaf.bsky.social's Catherine Connor, Elisha Dunn-Georgiou & our own Mitchell Warren for for today's discussion, “Reimagining #GlobalHealth Partnership in the Post-USAID Era at #MarComSummit. It's about trust, prioritization and protecting progress.